Showing results (1441-1450 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|September 13, 2014
Population pharmacokinetics of daclizumab high-yield process in healthy volunteers: integrated analysis of intravenous and subcutaneous, single- and multiple-dose administrationAhmed A Othman, Jonathan Q Tran, Meina T Tang, et al.Clinical Pharmacokinetics|October 16, 2014
Clinical pharmacokinetics and pharmacodynamics of the novel SGLT2 inhibitor ipragliflozinTakeshi Kadokura, Wenhui Zhang, Walter Krauwinkel, et al.Clinical Pharmacokinetics|May 31, 2013
Population pharmacokinetic analysis for hydrocodone following the administration of hydrocodone bitartrate extended-release capsulesMurad R Melhem, Christopher M Rubino, Stephen J Farr, et al.Clinical Pharmacokinetics|August 1, 1990
Pharmacokinetics of ketanserin in patients with cirrhosisD Lebrec, A Hadengue, C Gaudin, et al.Clinical Pharmacokinetics|August 1, 1990
Pharmacokinetic investigations in elderly patients. Clinical and ethical considerationsD R Abernethy, D L AzarnoffClinical Pharmacokinetics|June 29, 2013
Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerationsTiphaine Goulenok, Bruno FantinClinical Pharmacokinetics|June 12, 2013
Population pharmacokinetics of sifalimumab, an investigational anti-interferon-α monoclonal antibody, in systemic lupus erythematosusRajesh Narwal, Lorin K Roskos, Gabriel J RobbieClinical Pharmacokinetics|October 29, 2013
Insulin degludec: pharmacokinetics in patients with renal impairmentIstván Kiss, Gerhard Arold, Carsten Roepstorff, et al.Clinical Pharmacokinetics|October 19, 2013
Exposure-toxicity relationship of sorafenib in Japanese patients with renal cell carcinoma and hepatocellular carcinomaMasahide Fukudo, Takuma Ito, Tomoyuki Mizuno, et al.Clinical Pharmacokinetics|October 3, 2013
Random-effects linear modeling and sample size tables for two special crossover designs of average bioequivalence studies: the four-period, two-sequence, two-formulation and six-period, three-sequence, three-formulation designsFrancisco J Diaz, Michel J Berg, Ron Krebill, et al.Pageof 348